In This Section
Earlier this spring, the Food and Drug Administration (FDA) issued a notice in the Federal Register that invited the public to submit scientific information and comments on cannabis and cannabis products. We want to ensure that you know how to submit comments that will be convincing regulators and how to avoid common pitfalls we see in many comments. This webinar will help walk you through the comment submission process and give you advice on how to formulate a comment that will help convince the FDA.
This two part webinar series discusses the Cascade of Care Model for Medical Cannabis.
Our own David Mangone joined CannaTalk with Roz and Minorities 4 Medical Marijuana to participate in a discussion of equity in the medical cannabis industry. This conversation between David, Roz McCarthy, Erik Range, and Scheril Murray Powell was hosted on Facebook Live on May 17, 2019.
Michelle Newhart, PhD and William Dolphin discuss their new book, The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience. Learn what their research on mid-life patients in Colorado reveals about what it means to participate in a state medical cannabis program. Hear how patient experiences with medical cannabis fit with that of other medicines -- and don’t -- and hear how that's changing as medicalization marches forward alongside competing "recreational" definitions that complicate the issue.
American is experiencing an Opioid Crisis and looking for solutions. Could medical cannabis help? Dr. Ethan Russo and Americans for Safe Access (ASA) held this live webinar on September 6th, 2017 with the participation of ASA members across the country.
Intellectual property assets (patents, trademarks, copyrights, etc.) form the foundation of most companies' business plans, and can represent up to 80% of a company's valuation. But businesses in the cannabis industry face special challenges because most intellectual property assets are based in federal law. Find out more about those challenges, and what other types of protections are available instead, at this overview of intellectual property strategies especially for cannabis company founders, inventors and investors.
There needs to be standards, regulations, and traceability. Such responsibility is deeply imprinted in the botanical medicine and herbal product industries; Good Manufacturing Practices (or any GxP) are the same across industry and jurisdictional boundaries. At the state-level there has been a proliferation of policies and laws that relax cannabidiol issues, while operators and producers are voluntarily adopting good practices.
This webinar, provided by Patient Focused Certification (PFC), will cover the need for regulatory inspection preparedness in the cannabis industry. And the most common violations that result in fines and potentially the denial or loss of an operating license. Learn about how PFC services help cannabis operations pass regulatory inspections, specifically for phase II licensing in states such as Maryland.
John A. MacKay earned a B.A. in Chemistry from St. Lawrence University, and Ph.D. from the University of Vermont in chemistry focused on the synthesis for cancer fighting compounds. After positions teaching at Davidson College, Lyndon State College and University of Vermont (UVM), John joined Waters Corporation in 1983. His career has included many roles in innovative product development and currently leads the Strategic Technology team. He is widely recognized as scientific expert in sub and supercritical fluid for extraction and chromatography in the botanical space.
This webinar is an introduction to the Patient Focused Certification program and was recorded live on May 3, 2017. It was hosted by Jahan Marcu, Ph.D., Americans for Safe Access Chief Science Officer and Patient Focused Certification Auditor.
Americans for Safe Access Foundation (ASA) and The Answer Page, Inc. have created the Cannabis Care Certification (CCC) program to help doctors provide the best care for legal medical cannabis patients, and to help patients get the most from their medical cannabis use. CCC has been created by recognized world experts and includes online educational tools for medical professionals, patients, and their caregivers to better understand the role of cannabis therapeutics through a structured learning environment. The CCC program has been designed for individuals as well as for companies and organizations that need to meet state requirements for patient medical cannabis education or CME requirements for physicians.